These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1004 related articles for article (PubMed ID: 16862152)

  • 1. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.
    Thaker PH; Han LY; Kamat AA; Arevalo JM; Takahashi R; Lu C; Jennings NB; Armaiz-Pena G; Bankson JA; Ravoori M; Merritt WM; Lin YG; Mangala LS; Kim TJ; Coleman RL; Landen CN; Li Y; Felix E; Sanguino AM; Newman RA; Lloyd M; Gershenson DM; Kundra V; Lopez-Berestein G; Lutgendorf SK; Cole SW; Sood AK
    Nat Med; 2006 Aug; 12(8):939-44. PubMed ID: 16862152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neuroendocrine impact of chronic stress on cancer.
    Thaker PH; Lutgendorf SK; Sood AK
    Cell Cycle; 2007 Feb; 6(4):430-3. PubMed ID: 17312398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
    Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
    Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical stress promotes tumor growth in ovarian carcinoma.
    Lee JW; Shahzad MM; Lin YG; Armaiz-Pena G; Mangala LS; Han HD; Kim HS; Nam EJ; Jennings NB; Halder J; Nick AM; Stone RL; Lu C; Lutgendorf SK; Cole SW; Lokshin AE; Sood AK
    Clin Cancer Res; 2009 Apr; 15(8):2695-702. PubMed ID: 19351748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem-like ovarian cancer cells can serve as tumor vascular progenitors.
    Alvero AB; Fu HH; Holmberg J; Visintin I; Mor L; Marquina CC; Oidtman J; Silasi DA; Mor G
    Stem Cells; 2009 Oct; 27(10):2405-13. PubMed ID: 19658191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic effects of dopamine on tumor vasculature in ovarian carcinoma.
    Moreno-Smith M; Lee SJ; Lu C; Nagaraja AS; He G; Rupaimoole R; Han HD; Jennings NB; Roh JW; Nishimura M; Kang Y; Allen JK; Armaiz GN; Matsuo K; Shahzad MM; Bottsford-Miller J; Langley RR; Cole SW; Lutgendorf SK; Siddik ZH; Sood AK
    Neoplasia; 2013 May; 15(5):502-10. PubMed ID: 23633922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
    Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
    Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice.
    Kim LS; Huang S; Lu W; Lev DC; Price JE
    Clin Exp Metastasis; 2004; 21(2):107-18. PubMed ID: 15168728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic stress accelerates the development of endometriosis in mouse through adrenergic receptor β2.
    Long Q; Liu X; Qi Q; Guo SW
    Hum Reprod; 2016 Nov; 31(11):2506-2519. PubMed ID: 27664956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
    Wood JM
    Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antitumor and antiangiogenic activity of vascular endothelial growth factor receptor inhibition is potentiated by ErbB1 blockade.
    Sini P; Wyder L; Schnell C; O'Reilly T; Littlewood A; Brandt R; Hynes NE; Wood J
    Clin Cancer Res; 2005 Jun; 11(12):4521-32. PubMed ID: 15958638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidylinositol 3-kinase mediates angiogenesis and vascular permeability associated with ovarian carcinoma.
    Hu L; Hofmann J; Jaffe RB
    Clin Cancer Res; 2005 Nov; 11(22):8208-12. PubMed ID: 16299254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paris Saponin II suppresses the growth of human ovarian cancer xenografts via modulating VEGF-mediated angiogenesis and tumor cell migration.
    Xiao X; Yang M; Xiao J; Zou J; Huang Q; Yang K; Zhang B; Yang F; Liu S; Wang H; Bai P
    Cancer Chemother Pharmacol; 2014 Apr; 73(4):807-18. PubMed ID: 24638862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model.
    Byrne AT; Ross L; Holash J; Nakanishi M; Hu L; Hofmann JI; Yancopoulos GD; Jaffe RB
    Clin Cancer Res; 2003 Nov; 9(15):5721-8. PubMed ID: 14654557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling.
    Komuro A; Yashiro M; Iwata C; Morishita Y; Johansson E; Matsumoto Y; Watanabe A; Aburatani H; Miyoshi H; Kiyono K; Shirai YT; Suzuki HI; Hirakawa K; Kano MR; Miyazono K
    J Natl Cancer Inst; 2009 Apr; 101(8):592-604. PubMed ID: 19351925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.
    Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M
    Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growth factor receptor tyrosine kinases.
    Xu L; Yoneda J; Herrera C; Wood J; Killion JJ; Fidler IJ
    Int J Oncol; 2000 Mar; 16(3):445-54. PubMed ID: 10675474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis and ovarian cancer.
    Gómez-Raposo C; Mendiola M; Barriuso J; Casado E; Hardisson D; Redondo A
    Clin Transl Oncol; 2009 Sep; 11(9):564-71. PubMed ID: 19775995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined inhibition of vascular endothelial growth factor and platelet-derived growth factor signaling: effects on the angiogenesis, microcirculation, and growth of orthotopic malignant gliomas.
    Farhadi MR; Capelle HH; Erber R; Ullrich A; Vajkoczy P
    J Neurosurg; 2005 Feb; 102(2):363-70. PubMed ID: 15739567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.